A detailed history of Fmr LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,679,287 shares of ARVN stock, worth $66.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,679,287
Previous 2,388,954 12.15%
Holding current value
$66.9 Million
Previous $98.6 Million 27.68%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$24.46 - $40.4 $7.1 Million - $11.7 Million
290,333 Added 12.15%
2,679,287 $71.3 Million
Q1 2024

May 13, 2024

BUY
$36.38 - $52.31 $5.27 Million - $7.58 Million
144,935 Added 6.46%
2,388,954 $98.6 Million
Q4 2023

Feb 13, 2024

SELL
$14.19 - $42.33 $37.2 Million - $111 Million
-2,624,276 Reduced 53.91%
2,244,019 $92.4 Million
Q3 2023

Nov 13, 2023

BUY
$19.64 - $28.21 $9.17 Million - $13.2 Million
466,667 Added 10.6%
4,868,295 $95.6 Million
Q2 2023

Aug 11, 2023

SELL
$21.73 - $31.43 $28.6 Million - $41.4 Million
-1,316,403 Reduced 23.02%
4,401,628 $109 Million
Q1 2023

May 11, 2023

BUY
$26.15 - $37.26 $1.53 Million - $2.18 Million
58,561 Added 1.03%
5,718,031 $156 Million
Q4 2022

Feb 13, 2023

SELL
$32.47 - $57.24 $33.9 Million - $59.7 Million
-1,043,403 Reduced 15.57%
5,659,470 $194 Million
Q3 2022

Nov 10, 2022

SELL
$41.87 - $57.99 $27.6 Million - $38.3 Million
-660,320 Reduced 8.97%
6,702,873 $298 Million
Q2 2022

Aug 12, 2022

BUY
$36.01 - $74.24 $6.03 Million - $12.4 Million
167,390 Added 2.33%
7,363,193 $310 Million
Q1 2022

May 13, 2022

BUY
$60.27 - $81.57 $14.1 Million - $19.1 Million
234,155 Added 3.36%
7,195,803 $484 Million
Q4 2021

Feb 14, 2022

SELL
$65.85 - $96.21 $6.04 Million - $8.82 Million
-91,658 Reduced 1.3%
6,961,648 $572 Million
Q3 2021

Nov 15, 2021

BUY
$73.2 - $107.87 $78.4 Million - $115 Million
1,070,421 Added 17.89%
7,053,306 $580 Million
Q2 2021

Aug 13, 2021

BUY
$60.45 - $84.26 $362 Million - $504 Million
5,982,885 New
5,982,885 $461 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.33B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.